• Je něco špatně v tomto záznamu ?

Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner

K. Cizkova,

. 2018 ; 355 (-) : 156-163. [pub] 20180627

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012578

CYP epoxygenases metabolize arachidonic acid into four regioisomers of epoxyeicosatrienoic acids (EETs) which are hydrolysed into their corresponding diols by soluble epoxide hydrolase (sEH). EETs are very biologically active molecules. They promote proliferation and inhibit apoptosis as well as numerous other functions within organisms. Peroxisome proliferator-activated receptor α (PPARα) play role in regulation of CYP epoxygenases and sEH. PPARα is the ligand-dependent transcriptional factor which is activated by various compounds, including fibrates. The latter are widely used in clinical practice. This study investigates the changes in expression of CYP2C8, CYP2J2, and sEH in HEK293, HepG2, and HT-29 cell lines after fibrate treatment using two different incubation times. The results demonstrate that the effect of fibrates on arachidonic acid-metabolizing enzymes expression is concentration-dependent. Although CYP2C8 expression is downregulated by the fibrates treatment, the results reveal that changes in CYP2J2/sEH ratio are closely associated with cell proliferation and could explain the differing proliferation response of cells to different concentrations of fibrates.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012578
003      
CZ-PrNML
005      
20190412122932.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.taap.2018.06.025 $2 doi
035    __
$a (PubMed)29960002
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cizkova, Katerina $u Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic. Electronic address: katerina.cizkova@upol.cz.
245    10
$a Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner / $c K. Cizkova,
520    9_
$a CYP epoxygenases metabolize arachidonic acid into four regioisomers of epoxyeicosatrienoic acids (EETs) which are hydrolysed into their corresponding diols by soluble epoxide hydrolase (sEH). EETs are very biologically active molecules. They promote proliferation and inhibit apoptosis as well as numerous other functions within organisms. Peroxisome proliferator-activated receptor α (PPARα) play role in regulation of CYP epoxygenases and sEH. PPARα is the ligand-dependent transcriptional factor which is activated by various compounds, including fibrates. The latter are widely used in clinical practice. This study investigates the changes in expression of CYP2C8, CYP2J2, and sEH in HEK293, HepG2, and HT-29 cell lines after fibrate treatment using two different incubation times. The results demonstrate that the effect of fibrates on arachidonic acid-metabolizing enzymes expression is concentration-dependent. Although CYP2C8 expression is downregulated by the fibrates treatment, the results reveal that changes in CYP2J2/sEH ratio are closely associated with cell proliferation and could explain the differing proliferation response of cells to different concentrations of fibrates.
650    _2
$a kyseliny arachidonové $x metabolismus $7 D001095
650    _2
$a cytochrom P450 CYP2C8 $x biosyntéza $x genetika $7 D065727
650    _2
$a systém (enzymů) cytochromů P-450 $x biosyntéza $x genetika $7 D003577
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a epoxid hydrolasy $x biosyntéza $7 D004851
650    _2
$a deriváty kyseliny fibrové $x farmakologie $7 D058607
650    _2
$a regulace genové exprese enzymů $x účinky léků $7 D015971
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a buňky HT-29 $7 D019073
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x farmakologie $7 D007004
650    _2
$a PPAR alfa $x účinky léků $x metabolismus $7 D047493
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
773    0_
$w MED00010691 $t Toxicology and applied pharmacology $x 1096-0333 $g Roč. 355, č. - (2018), s. 156-163
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29960002 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190412122951 $b ABA008
999    __
$a ok $b bmc $g 1391888 $s 1050883
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 355 $c - $d 156-163 $e 20180627 $i 1096-0333 $m Toxicology and applied pharmacology $n Toxicol Appl Pharmacol $x MED00010691
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...